Tom Milicevic is an experienced commercial, financial and management accountant with more than 20 years of experience working with a number of major Australian and international public companies. He has specific financial expertise in medical device and biotech companies. Prior to joining OncoSil Medical in 2015, Mr Milicevic was chief executive and chief financial officer of orthopaedic medical device company, Allegra Orthopaedics, where he successfully led the company through its IPO and ASX listing. Mr Milicevic was also chief financial officer of Babcock & Brown Residential Land Partners, an ASX-listed fund, where he was the financial lead on the stapled security’s $175m IPO. His previous roles include chief financial officer and company secretary of an ASX-listed oncology biotech, and senior finance and accounting roles with ASX 100 Australian companies. Mr Milicevic is a qualified Certified Practising Accountants (CPA) and a Fellow of the Australian Society of CPA’s. He also has a Bachelor of Commerce from the Western Sydney University, and has completed an MBA at Macquarie Graduate School of Management in Sydney.
